Total Funding
27
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Develops and markets sterile catheter insertion systems that solve IV catheterization.
Shai Amisar: CEO
About the Company
Flexicath develops and markets sterile catheter insertion systems that solve the most problematic and expensive issues of Midterm (up to 29 days Indwelling) IV catheterization. Flexicath is a pioneer and in the Midterm category, coupling proprietary new innovations and proven industry technology to deliver the world’s best and safest midterm
catheter. Their M/29 Midterm Catheter System was designed to answer an obvious need for a safe, easy-to-insert catheter for intermediate dwell applications. It is the only touch-free midline that can be placed in under 10 minutes following minimal training.
